• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洛地平对人体的急性利尿/利钠特性。

Acute diuretic/natriuretic properties of felodipine in man.

作者信息

Edgar B, Bengtsson B, Elmfeldt D, Lundborg P, Nyberg G, Raner S, Rönn O

出版信息

Drugs. 1985;29 Suppl 2:176-84. doi: 10.2165/00003495-198500292-00032.

DOI:10.2165/00003495-198500292-00032
PMID:3987546
Abstract

The natriuretic/diuretic effect of felodipine was investigated in 2 studies. The first was performed as an open study using intravenous and oral felodipine in healthy male subjects. The second was a double-blind study where a high and a low dose of oral felodipine were given to hypertensive patients on long term treatment with beta-blockers; the different doses of felodipine were chosen to decrease and to have no effect on the blood pressure, respectively. In both studies an oral placebo solution was used as a reference. Felodipine caused a significant increase in natriuresis. Compared with placebo and corrected for total 24-hour excretion, the sodium output during the first 4 hours after drug administration was increased by 219 +/- 53% (mean +/- SEM) after intravenous administration in healthy subjects (p less than 0.01) and by 80 +/- 43% in the first 3 hours after the high dose in hypertensive patients (p less than 0.05). For the same period, the urine excretion was increased by 114 +/- 38% (p less than 0.05) in the healthy subjects and by 36 +/- 22% in the hypertensive patients (not significant). However, the 24-hour excretion of urine, Na+ and K+ was not significantly changed from placebo. A significantly lower blood pressure was recorded after the higher dose (0.10 mg/kg) when given to hypertensive patients, but no such effect was seen after the lower dose (0.01 mg/kg) or in healthy subjects. The changes in diastolic blood pressure seem to be negatively correlated with the diuretic but not with the natriuretic effect.

摘要

在两项研究中对非洛地平的利钠/利尿作用进行了调查。第一项研究是在健康男性受试者中开展的开放研究,使用了静脉注射和口服非洛地平。第二项研究是一项双盲研究,对长期接受β受体阻滞剂治疗的高血压患者给予高剂量和低剂量的口服非洛地平;选择不同剂量的非洛地平分别用于降低血压和对血压无影响。在两项研究中均使用口服安慰剂溶液作为对照。非洛地平引起显著的利钠增加。与安慰剂相比并校正24小时总排泄量后,健康受试者静脉给药后给药后前4小时的钠排出量增加了219±53%(均值±标准误)(p<0.01),高血压患者高剂量给药后前3小时增加了80±43%(p<0.05)。在同一时期,健康受试者的尿量排泄增加了114±38%(p<0.05),高血压患者增加了36±22%(无显著差异)。然而,24小时的尿、Na+和K+排泄量与安慰剂相比无显著变化。高血压患者给予较高剂量(0.10mg/kg)后记录到血压显著降低,但较低剂量(0.01mg/kg)给药后或在健康受试者中未观察到这种效果。舒张压的变化似乎与利尿作用呈负相关,但与利钠作用无关。

相似文献

1
Acute diuretic/natriuretic properties of felodipine in man.非洛地平对人体的急性利尿/利钠特性。
Drugs. 1985;29 Suppl 2:176-84. doi: 10.2165/00003495-198500292-00032.
2
Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.非洛地平对健康血压正常志愿者的血流动力学、激素及利尿作用。
Drugs. 1985;29 Suppl 2:26-35. doi: 10.2165/00003495-198500292-00006.
3
Dose-dependent effects of felodipine on diuresis and natriuresis in healthy subjects.非洛地平对健康受试者利尿和利钠的剂量依赖性效应。
J Cardiovasc Pharmacol. 1988 Aug;12(2):134-9. doi: 10.1097/00005344-198808000-00002.
4
Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.
Eur J Clin Pharmacol. 1995;47(5):395-400. doi: 10.1007/BF00196851.
5
Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.静脉注射非洛地平对血压正常和高血压受试者的血流动力学影响。
Drugs. 1985;29 Suppl 2:144-53. doi: 10.2165/00003495-198500292-00025.
6
Renal and antihypertensive effects of felodipine in hypertensive patients.非洛地平对高血压患者的肾脏及降压作用
J Hypertens Suppl. 1985 Dec;3(3):S161-3.
7
Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.
Eur J Pharmacol. 1985 Jul 11;113(1):25-36. doi: 10.1016/0014-2999(85)90339-5.
8
Effects of felodipine on renal function in animals.
Drugs. 1985;29 Suppl 2:168-75. doi: 10.2165/00003495-198500292-00031.
9
Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.非洛地平对原发性高血压患者利钠作用、心房利钠因子、肾素-血管紧张素-醛固酮系统及血压的影响
Clin Ther. 1988;10(6):694-703.
10
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients.新型血管扩张性钙拮抗剂非洛地平对高血压患者的降压及水钠平衡作用
Drugs. 1985;29 Suppl 2:185-91. doi: 10.2165/00003495-198500292-00033.

引用本文的文献

1
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.用于药物相互作用建模的CYP3A4底物非洛地平的基于生理的药代动力学和药效学模型。
Pharmaceutics. 2022 Jul 15;14(7):1474. doi: 10.3390/pharmaceutics14071474.
2
The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.
Eur J Clin Pharmacol. 1993;45(4):327-32. doi: 10.1007/BF00265949.
3
Do calcium channel blockers have renal protective effects?钙通道阻滞剂有肾脏保护作用吗?

本文引用的文献

1
Determination of felodipine in plasma by capillary gas chromatography with electron capture detection.采用带电子捕获检测的毛细管气相色谱法测定血浆中的非洛地平。
J Pharm Biomed Anal. 1984;2(3-4):519-26. doi: 10.1016/0731-7085(84)80055-2.
2
Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements.使用示波法分析体循环动脉搏动血流对中心主动脉压进行无创估计:间接测量肱动脉收缩压、舒张压和平均压与同步直接测量升主动脉压的对比研究。
Am Heart J. 1982 May;103(5):879-86. doi: 10.1016/0002-8703(82)90403-3.
3
Drugs Aging. 1994 Oct;5(4):263-87. doi: 10.2165/00002512-199405040-00004.
4
Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.
Eur J Clin Pharmacol. 1995;47(5):395-400. doi: 10.1007/BF00196851.
5
Acute haemodynamic effects of felodipine in congestive heart failure.非洛地平在充血性心力衰竭中的急性血流动力学效应。
Eur J Clin Pharmacol. 1985;28(5):489-93. doi: 10.1007/BF00544056.
6
Acute renal effects of oral felodipine in normal man.
Eur J Clin Pharmacol. 1987;32(1):17-22. doi: 10.1007/BF00609952.
7
Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect?硝苯地平对高血压患者和血压正常对照者的急性利钠作用——近端小管效应?
Eur J Clin Pharmacol. 1987;32(2):121-6. doi: 10.1007/BF00542183.
8
Treatment of essential hypertension with felodipine in combination with a diuretic.
Eur J Clin Pharmacol. 1986;30(2):133-9. doi: 10.1007/BF00614290.
9
Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects.
Clin Pharmacokinet. 1988 Jun;14(6):374-83. doi: 10.2165/00003088-198814060-00004.
10
Felodipine versus Moduretic. A double-blind parallel-group multicentre study.
Drugs. 1987;34 Suppl 3:162-9. doi: 10.2165/00003495-198700343-00035.
Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.
新型血管扩张剂非洛地平对健康受试者的血流动力学影响。
Eur J Clin Pharmacol. 1983;24(1):49-53. doi: 10.1007/BF00613926.
4
Calcium antagonists. Clinical use in the treatment of systemic hypertension.钙拮抗剂。在系统性高血压治疗中的临床应用。
Drugs. 1983 Feb;25(2):154-77. doi: 10.2165/00003495-198325020-00004.
5
Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension.
Eur J Clin Pharmacol. 1983;25(5):571-5. doi: 10.1007/BF00542340.
6
Minoxidil.米诺地尔
Ann Intern Med. 1981 Jan;94(1):61-5. doi: 10.7326/0003-4819-94-1-61.
7
The dntidiuretic action of diazoxide.二氮嗪的利尿作用。 (注:原文中“dntidiuretic”可能有误,推测应为“diuretic”)
Clin Sci. 1972 Feb;42(2):145-52. doi: 10.1042/cs0420145.
8
Vasodilator drugs in the treatment of hypertension.
Arch Intern Med. 1974 Jun;133(6):1017-27.
9
Acute haemodynamic effects of felodipine and verapamil in man, singly and with metoprolol.非洛地平与维拉帕米单用及与美托洛尔合用对人体的急性血流动力学效应。
Drugs. 1985;29 Suppl 2:16-25. doi: 10.2165/00003495-198500292-00005.
10
Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.静脉注射非洛地平对血压正常和高血压受试者的血流动力学影响。
Drugs. 1985;29 Suppl 2:144-53. doi: 10.2165/00003495-198500292-00025.